Enliven Therapeutics Cash Flow Statement 2019-2025 | ELVN

Fifteen years of historical annual cash flow statements for Enliven Therapeutics (ELVN).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202420232022202120202019
$-89.02$-71.58$-37.66$-51.38$-41.36$-23.46
$0.74$-4.31$0.22$0.25$0.22$0.01
$19.63$13.22$4.93$3.85$2.23$0.90
$20.37$8.91$5.15$4.10$2.45$0.91
$0$0$0$0$0$0
$0$0$0$0$0$0
$0.81$-2.25$0.41$0.39$0.31$0.75
$-5.10$-4.01$-1.59$-0.27$-0.55$-1.38
$-4.54$1.40$0.44$0.51$1.51$0.67
$-73.19$-61.27$-32.08$-46.77$-37.40$-21.88
$-0.04$-0.15$-0.61$-0.01$-0.02$-0.14
$0$0$0$0$0$0
$0$0$0$0$0$0
$-36.83$-148.26$0.00$-1.62$-16.70$-23.92
$0$0$0$0$0$0
$-36.83$-148.26$0$-1.62$-16.70$-23.92
$0.87$0$0$0$0$0
$-36.00$-148.41$-0.61$-1.63$-16.72$-24.06
$0$0$0$0$0$0
$0$0$0$47.00$0$0
$0$0$0$47.00$0$0
$93.98$0.40$0.59$0.86$81.45$0
$93.98$0.40$0.59$0.86$98.60$45.58
$0$0$0$0$0$0
$39.19$234$-2.39$1.24$-1.72$-2.00
$133$234$-1.80$49.10$96.88$43.58
$23.98$24.61$-34.49$0.70$42.76$-2.36
$20.17$12.91$3.19$3.85$2.23$0.90
$0$0$0$0$0$0